/100
Desktop 64/100
Mobile 41/100
Drugtargetreview.com is a website that provides drug discovery news, research papers, and application notes. The website's name and title suggest that the site is focused on drug targets and drug discovery. The main objective of this website seems to be to provide useful and relevant information related to drug discovery. It covers the latest technologies and news on drug discovery and offers research papers and application notes that researchers and professionals in the pharmaceutical industry can use.
The site is hosted by CLOUDFLARENET - Cloudflare, Inc., US hosting. Cloudflare is a reputable and reliable hosting provider that gives users fast and secure websites that are well-protected against hackers. The SSL certificate used by the site was also issued by Cloudflare, which adds an extra layer of security to the site.
Drugtargetreview.com seems to be a family-friendly site that is safe for all ages. There is no adult or controversial content on the site, and the information provided is primarily geared toward professionals and researchers working in drug discovery.
The site has a PageSpeed Insight speed score of 53 out of 100. This means that it may take longer to load, leading to a poor user experience. The desktop score of 64 is better than the mobile score of 41, indicating that the mobile version of the site may need some optimization. The website owner may need to address some issues to improve website speed, which can improve bounce rate, user engagement, and conversion rates.
Drugtargetreview.com seems to be a content-rich website that provides valuable information related to drug discovery. The site's design is clean and straightforward, with easy-to-navigate sections. It offers news, research papers, and application notes that can help pharmaceutical researchers stay informed and up-to-date with the latest developments in the field. However, the site could benefit from some optimization to improve its PageSpeed Insight scores and provide a better user experience.
Domain | sni.cloudflaressl.com |
Issuer Organization | CloudFlare, Inc. |
Issuer | Cloudflare Inc ECC CA-3 |
Algorithm | ecdsa-with-SHA256 |
Valid form | 07/19/2020 |
Expiration | 07/19/2021 |
Signed | Certificate is not self signed |
Additional Domains |
*.drugtargetreview.com drugtargetreview.com sni.cloudflaressl.com |
Alexa Rank shows how popular drugtargetreview.com is in comparison with other sites. The most popular site has Alexa Rank equals 1. If drugtargetreview.com has Alexa Rank equals 100,000, then it is in TOP 100,000 popular sites in the world. The rank is calculated using a combination of average daily visitors to drugtargetreview.com and pageviews on drugtargetreview.com over the past 3 months.
ASN ID: 13335
ASN Title: CLOUDFLARENET - Cloudflare, Inc., USLast Update: 03/19/2024
#
# ARIN WHOIS data and services are subject to the Terms of Use
# available at: https://www.arin.net/whois_tou.html
#
# If you see inaccuracies in the results, please report at
# https://www.arin.net/resources/whois_reporting/index.html
#
# Copyright 1997-2018, American Registry for Internet Numbers, Ltd.
#
ASNumber: 13335
ASName: CLOUDFLARENET
ASHandle: AS13335
RegDate: 2010-07-14
Updated: 2017-02-17
Comment: All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Ref: https://rdap.arin.net/registry/autnum/13335
OrgName: Cloudflare, Inc.
OrgId: CLOUD14
Address: 101 Townsend Street
City: San Francisco
StateProv: CA
PostalCode: 94107
Country: US
RegDate: 2010-07-09
Updated: 2017-02-17
Comment: All Cloudflare abuse reporting can be done via https://www.cloudflare.com/abuse
Ref: https://rdap.arin.net/registry/entity/CLOUD14
OrgTechHandle: ADMIN2521-ARIN
OrgTechName: Admin
OrgTechPhone: +1-650-319-8930
OrgTechEmail: rir@cloudflare.com
OrgTechRef: https://rdap.arin.net/registry/entity/ADMIN2521-ARIN
OrgAbuseHandle: ABUSE2916-ARIN
OrgAbuseName: Abuse
OrgAbusePhone: +1-650-319-8930
OrgAbuseEmail: abuse@cloudflare.com
OrgAbuseRef: https://rdap.arin.net/registry/entity/ABUSE2916-ARIN
OrgNOCHandle: NOC11962-ARIN
OrgNOCName: NOC
OrgNOCPhone: +1-650-319-8930
OrgNOCEmail: noc@cloudflare.com
OrgNOCRef: https://rdap.arin.net/registry/entity/NOC11962-ARIN
RNOCHandle: NOC11962-ARIN
RNOCName: NOC
RNOCPhone: +1-650-319-8930
RNOCEmail: noc@cloudflare.com
RNOCRef: https://rdap.arin.net/registry/entity/NOC11962-ARIN
RTechHandle: ADMIN2521-ARIN
RTechName: Admin
RTechPhone: +1-650-319-8930
RTechEmail: rir@cloudflare.com
RTechRef: https://rdap.arin.net/registry/entity/ADMIN2521-ARIN
RAbuseHandle: ABUSE2916-ARIN
RAbuseName: Abuse
RAbusePhone: +1-650-319-8930
RAbuseEmail: abuse@cloudflare.com
RAbuseRef: https://rdap.arin.net/registry/entity/ABUSE2916-ARIN
#
# ARIN WHOIS data and services are subject to the Terms of Use
# available at: https://www.arin.net/whois_tou.html
#
# If you see inaccuracies in the results, please report at
# https://www.arin.net/resources/whois_reporting/index.html
#
# Copyright 1997-2018, American Registry for Internet Numbers, Ltd.
#
Domain Name: DRUGTARGETREVIEW.COM
Registry Domain ID: 1824154786_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.enom.com
Registrar URL: http://www.enomdomains.com
Updated Date: 2023-08-04T14:00:34Z
Creation Date: 2013-08-29T10:29:35Z
Registry Expiry Date: 2024-08-29T10:29:35Z
Registrar: eNom, LLC
Registrar IANA ID: 48
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: ERIN.NS.CLOUDFLARE.COM
Name Server: RAM.NS.CLOUDFLARE.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2023-10-10T17:06:28Z
Host | A Record | TTL |
---|
Host | MX Record | Priority | TTL |
---|
Host | NS Record | TTL |
---|
Host | TXT Record | TTL |
---|
Last tested: 09/02/2018
Total Resources | 130 |
Number of Hosts | 15 |
Static Resources | 100 |
JavaScript Resources | 57 |
CSS Resources | 22 |
Last tested: 01/02/2018
Total Resources | 104 |
Number of Hosts | 12 |
Static Resources | 83 |
JavaScript Resources | 53 |
CSS Resources | 21 |